🇺🇸 The U.S. Pancreatic Cancer Precision Medicine Market is projected to rise from US$183.61 million in 2024 to US$694.48 million by 2033, expanding at a remarkable CAGR of 15.93% 📈 This strong growth reflects the U.S. healthcare system’s shift toward data-driven oncology, emphasizing early detection, precision treatment, and improved survivorship. 🔗 Read full report: 👉 https://www.renub.com/united-states-pancreatic-cancer-precision-medicine-market-p.php 📊 #PrecisionMedicine #Oncology #PancreaticCancer #HealthcareInnovation #PersonalizedMedicine #CancerResearch #Biotech #USMarket #RenubResearch